Employer Strategies to Manage Cell & Gene Therapy

Description

Employers are concerned about the growing use and price of Cell and Gene Therapies (CGTs). One CGT claim can destroy the health plan’s budget. They provide life-preserving and life-saving benefits, profoundly affecting patients and their families. While the successes and growth are extraordinary, they are also frequently the source of an employer’s highest cost claim, often administered in single doses costing between $300,000 and $3.5 million per treatment. The program's purpose will be for employers to gain insights into how best to determine population and pipeline risk; explore coverage options; understand non-traditional payment options; learn about new care delivery approaches; and offer targeted employee communications and education. This webinar will cover: •What are CGTs •How will they impact the future of employer-sponsored coverage •What strategies can employers take to integrate new payment models •How a large national employer implemented its CGT strategy All attending this webinar will receive a CGT implementation roadmap!